#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypomagnesaemia Sickle cell disease Acute graft versus host disease in skin Pneumonia Mitochondrial encephalomyopathy B-cell lymphoma refractory Ocular myasthenia Craniopharyngioma Cholangiosarcoma Neurofibroma Myxofibrosarcoma Malignant central nervous system neoplasm Infantile spasms Osteochondrodysplasia Stevens-Johnson syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Basic Information Congenital generalised lipodystrophy Hereditary ataxia – Life with Disease Epidermolysis bullosa – Life with Disease Alternating hemiplegia of childhood – Basic Information Krabbe’s disease – Treatment Mucopolysaccharidosis – Diagnostics Bronchopulmonary dysplasia – Treatment IgA nephropathy – Basic Information Hyperoxaluria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Jnj-64042056 Atomoxetine Mva-Hbvac Islatravir Poa Pratensis Pollen Extract Psma-11 Nacystelyn IMB 101 Tafasitamab Canakinumab Formoterol Fumarate Pehero Glibenclamide A/H1N1 INFLUENZA VACCINE CARBACHOL Tasquinimod Fosfomycin Trometamol Treg02 Acoramidis Hydrochloride Cft1946 More therapies…

    Learn about Your Condition

    Chronic disease Primary hypogonadism Bone sarcoma Endometrial cancer Laryngeal cancer Trisomy 21 Infant sedation Ejection fraction normal Hepatotoxicity Vestibular disorder Bile acid synthesis disorder Pemphigoid Glioblastoma Meniere's disease Gastrointestinal disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic kidney disease

  • Study of the effect of empagliflozin on protein levels in the urine for patients with type 2 diabetes and kidney disease.

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Empagliflozin
    France

  • A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    • Chronic kidney disease
    Investigated Drugs:
    • SC0062
    • Dapagliflozin
    Denmark Finland The Netherlands

  • Study of SP16 to Prevent Acute Kidney Injury in Patients with Chronic Kidney Disease Undergoing Heart Surgery with Heart-Lung Machine

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Mitral valve disease
    • Arteriosclerosis coronary artery
    • Chronic kidney disease
    Investigated Drugs:
    • SP16
    Germany

  • Study of eplerenone in patients with heart failure and reduced ejection fraction who also have severe chronic kidney disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Altizide
    • Micronised Spironolactone
    Sweden

  • Study on Dapagliflozin for Patients with Chronic Kidney Disease or Kidney Failure Undergoing Hemodialysis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Haemodialysis
    • Renal failure
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Austria

  • Study on Finerenone for Slowing Chronic Kidney Disease Progression in Patients Receiving Standard Care

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Italy
Previous Page
1 … 4 5 6 7 8 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!